Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
暂无分享,去创建一个
D. Connolly | P. Familletti | H. Gerlach | D. Stern | M. Gerlach | M. Clauss | F. Wang | J. Brett | J. Olander | Y. C. Pan | Y.-C.E Pan | Y. Pan | Y. C. Pan | Y. Pan | Y. C. Pan
[1] M. Meltzer,et al. Tumor necrosis factor. , 1991, Journal of the American Academy of Dermatology.
[2] J. Pearson. Endothelial cell biology. , 1991, Radiology.
[3] P. Familletti,et al. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. , 1990, The Journal of biological chemistry.
[4] C. Nathan,et al. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents , 1990, The Journal of experimental medicine.
[5] D. Rifkin,et al. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells , 1990, The Journal of cell biology.
[6] D. Connolly,et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.
[7] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[8] D. Connolly,et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.
[9] H. Gerlach,et al. Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin [published erratum appears in J Exp Med 1989 Nov 1;170(5):1793] , 1989, The Journal of experimental medicine.
[10] D. Rifkin,et al. Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.
[11] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[12] H. Gerlach,et al. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins , 1989, The Journal of experimental medicine.
[13] W. Konigsberg,et al. Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity , 1989, Journal of cellular physiology.
[14] H. Gerlach,et al. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas , 1988, The Journal of experimental medicine.
[15] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Matsudaira,et al. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. , 1987, The Journal of biological chemistry.
[17] R. Bizios,et al. Endothelial monolayer permeability to macromolecules. , 1987, Federation proceedings.
[18] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[19] Y. Nemerson,et al. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. , 1986, Biochemistry.
[20] B. Beutler,et al. Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.
[21] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[22] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[23] T. Lyberg,et al. Cellular cooperation in endothelial cell thromboplastin synthesis , 1983, British journal of haematology.
[24] G. Broze. Binding of human factor VII and VIIa to monocytes. , 1982, The Journal of clinical investigation.
[25] T. Edgington,et al. Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides. , 1982, Journal of immunology.
[26] A. Fluks. Three-step isolation of human blood monocytes using discontinuous density gradients of Percoll. , 1981, Journal of immunological methods.
[27] A. Allison,et al. Tissue Thromboplastin Activity of Isolated Human Monocytes , 1978, Thrombosis and Haemostasis.
[28] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[29] B. Benacerraf,et al. The role of the reticuloendothelial system in the host reaction to neoplasia. , 1961, Cancer research.
[30] P. Familletti,et al. Techniques for Mammalian Cell Immobilization , 1988, Bio/Technology.
[31] J. Folkman,et al. Angiogenic factors. , 1987, Science.
[32] E. Jaffe. Culture and identification of large vessel endothelial cells , 1984 .
[33] Y. Nemerson,et al. Tissue factor revisited. , 1982, Progress in hemostasis and thrombosis.